Astellas Pharma Inc
F:YPHA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Astellas Pharma Inc
F:YPHA
|
JP |
|
Alteogen Inc
KOSDAQ:196170
|
KR |
|
Elemental Royalty Corp
NASDAQ:ELE
|
CA |
|
A
|
Aptamer Group PLC
LSE:APTA
|
UK |
|
Mayfield Childcare Ltd
ASX:MFD
|
AU |
|
S
|
Samart Digital PCL
SET:SDC
|
TH |
|
C
|
CI Group PCL
SET:CIG
|
TH |
|
Canoo Inc
NASDAQ:GOEV
|
US |
|
First Financial Bancorp
NASDAQ:FFBC
|
US |
|
Inversa Prime Socimi SA
MAD:YIPS
|
ES |
|
M
|
MK Real Estate Development PCL
SET:MK
|
TH |
|
D
|
Deutsche Grundstuecksauktionen vormals Berliner Grundstuecksauktionen AG
XMUN:DGR
|
DE |
|
Signify NV
AEX:LIGHT
|
NL |
|
T
|
TIME dotCom Bhd
KLSE:TIMECOM
|
MY |
|
S
|
Shalag Industries Ltd
TASE:SALG
|
IL |
|
Lithia Motors Inc
F:LMO
|
US |
|
W
|
Wonpung Mulsan Co Ltd
KOSDAQ:008290
|
KR |
|
Commercial Syn Bags Ltd
NSE:COMSYN
|
IN |
|
Baker Boyer Bancorp
OTC:BBBK
|
US |
Wall St Price Targets
YPHA Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for YPHA is 12.42 EUR with a low forecast of 8.83 EUR and a high forecast of 16.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YPHA's stock price target?
Price Target
12.42
EUR
According to Wall Street analysts, the average 1-year price target for YPHA is 12.42 EUR with a low forecast of 8.83 EUR and a high forecast of 16.75 EUR.
What is the Revenue forecast for Astellas Pharma Inc?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -4%.
What is the Gross Profit forecast for Astellas Pharma Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.
What is the Pre-Tax Income forecast for Astellas Pharma Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.
What is the Net Income forecast for Astellas Pharma Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.
